Jorge M. Gonçalves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jorge M. Gonçalves has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alice Maria Dias
CQUM‐Centre of Chemistry University of Minho Braga Portugal
1 shared publication - Bruna F. Silva
CEB—Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
1 shared publication - Cristina Pereira-Wilson
Department of Biology, University of Minho, 4710-057 Braga, Portugal
1 shared publication Eva Q. Pereira
CQUM – Chemistry Centre, Department of Chemistry University of Minho 4710-057 Braga Portugal
1 shared publication- Paulo J. G. Coutinho
Physics Centre of Minho and Porto Universities (CF-UM-UP), Department of Physics, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
1 shared publication Soraia P. S. Fernandes
CQUM – Chemistry Centre, Department of Chemistry University of Minho 4710-057 Braga Portugal
1 shared publication
Latest Publications
- Open Access
- 24 May 2024
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 27 (22) , e202400253
Novel Imidazole‐based Hydrazonoyl Cyanides and Amidrazones Containing N(N,O)‐Heterocycles: Selective Synthesis, Reaction Mechanisms and Preliminary Anticancer Evaluation
Two series of novel hybrid heterocyclic compounds that combine the imidazole ring with bioactive piperidine, morpholine or piperazine heterosystems, through a hydrazone unit, were easily obtained by two competitive pathways. Starting from 5‐amino‐4‐cyanoformimidoyl imidazoles and 1‐aminopiperidine, 4‐aminomorpholine or 1‐amino‐4‐methylpiperazine under mild acidic media led to the selective synthesis of 5‐aminoimidazole 4‐carboxamidrazones, whereas the corresponding 4‐hydrazonoyl cyanide derivatives were obtained under stronger acidic conditions. These highly functionalized imidazoles provide convenient synthetic precursors to a vast array of heterocycles with potential pharmaceutical applications. The reaction mechanisms were elucidated on the basis of experimental assays and in silico calculations. The compounds were screened against colorectal cancer HCT116‐p53 wt cell line, and significant IC50 values of 3.69 μM and 4.83 μM were obtained.
- 24 May 2024
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 27 (22) , e202400253
Open AccessNovel Imidazole‐based Hydrazonoyl Cyanides and Amidrazones Containing N(N,O)‐Heterocycles: Selective Synthesis, Reaction Mechanisms and Preliminary Anticancer Evaluation
Two series of novel hybrid heterocyclic compounds that combine the imidazole ring with bioactive piperidine, morpholine or piperazine heterosystems, through a hydrazone unit, were easily obtained by two competitive pathways. Starting from 5‐amino‐4‐cyanoformimidoyl imidazoles and 1‐aminopiperidine, 4‐aminomorpholine or 1‐amino‐4‐methylpiperazine under mild acidic media led to the selective synthesis of 5‐aminoimidazole 4‐carboxamidrazones, whereas the corresponding 4‐hydrazonoyl cyanide derivatives were obtained under stronger acidic conditions. These highly functionalized imidazoles provide convenient synthetic precursors to a vast array of heterocycles with potential pharmaceutical applications. The reaction mechanisms were elucidated on the basis of experimental assays and in silico calculations. The compounds were screened against colorectal cancer HCT116‐p53 wt cell line, and significant IC50 values of 3.69 μM and 4.83 μM were obtained.